Filing Details

Accession Number:
0001209191-18-064135
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-12-26 19:56:55
Reporting Period:
2018-12-21
Accepted Time:
2018-12-26 19:56:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1513818 Aravive Inc. ARAV Pharmaceutical Preparations (2834) 264106690
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1723780 Kevin Haas C/O Aravive, Inc.
Lyondellbassell Tower, 1221 Mckinney St.
Houston TX 77010
Vp, Finance And Pao No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-12-21 686 $3.22 11,162 No 4 S Direct
Common Stock Disposition 2018-12-21 25 $3.23 11,137 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant.